Cohen Cheryl 4
4 · Celldex Therapeutics, Inc. · Filed Jun 20, 2023
Insider Transaction Report
Form 4
Cohen Cheryl
Director
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2023-06-15+11,300→ 11,300 totalExercise: $36.87From: 2024-06-15Exp: 2033-06-15→ Common Stock (11,300 underlying)
Footnotes (1)
- [F1]Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan.